Skip to main content
Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.990
-0.180 (-5.68%)
At close: Nov 20, 2024, 4:00 PM
3.050
+0.060 (2.01%)
After-hours: Nov 20, 2024, 5:03 PM EST

Prime Medicine Revenue

Prime Medicine had revenue of $209.00K in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $800.00K.

Revenue (ttm)
$800.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$3,419
Employees
234
Market Cap
381.51M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 20205.21M--
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DocGo 694.97M
Esperion Therapeutics 295.45M
Revance Therapeutics 256.95M
Sonida Senior Living 253.20M
Canopy Growth 207.63M
Rigel Pharmaceuticals 157.37M
Aquestive Therapeutics 58.90M
Sangamo Therapeutics 52.29M
Revenue Rankings

PRME News

More News